Matthew Giegengack, MD
- Associate Professor, Ophthalmology
Matthew Giegengack, MD
- Education
- MD, Columbia University College of Physicians and Surgeons, 2002
- Residency
- Internal Medicine, Cabrini Medical Center, 2003
- Ophthalmology, Casey Eye Institute, 2006
- Fellowship
- Cornea and External Disease, Casey Eye Institute, 2007
- Board Certifications
- American Board of Ophthalmology, Ophthalmology
- Positions
- Associate Professor, Ophthalmology
- Departments and Affiliations
- Ophthalmology
- Office of Global Health
Research
- Bioengineered multilayered human corneas from discarded human corneal tissue. Zhang Z, Niu G, Choi JS, Giegengack M, Atala A, Soker S. Biomed Mater. 2015 Jun; 10(3):035012.
- Heparin-modified gelatin scaffolds for human corneal endothelial cell transplantation. Niu G, Choi JS, Wang Z, Skardal A, Giegengack M, Soker S. Biomaterials. 2014 Apr; 35(13):4005-14.
- Factors affecting successful isolation of human corneal endothelial cells for clinical use. Choi JS, Kim EY, Kim MJ, Khan FA, Giegengack M, D'Agostino R, Criswell T, Khang G, Soker S. Cell Transplant. 2014; 23(7):845-54.
- In vitro evaluation of the interactions between human corneal endothelial cells and extracellular matrix proteins. Choi JS, Kim EY, Kim MJ, Giegengack M, Khan FA, Khang G, Soker S. Biomed Mater. 2013 Feb; 8(1):014108.
- Oral mucosal graft with amniotic membrane transplantation for total limbal stem cell deficiency. Liu J, Sheha H, Fu Y, Giegengack M, Tseng SC. Am. J. Ophthalmol. 2011 Nov; 152(5):739-47.e1.